ArticleOncology letters2024

Irinotecan plus raltitrexed as second‑line chemotherapy for metastatic colorectal cancer: A retrospective study.

Jie Lian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.